Vatelizumab
Product Specifications
CAS Number
1238217-55-4
Target
Integrin
Related Pathways
Cytoskeletal Signaling
Purity
0.9954
Bioactivity
Vatelizumab is a humanised monoclonal antibody targeting Integrin ?2?1 (very late antigen 2, VLA-2, CD49b), which enhances the frequency of regulatory T cells via the p38 MAPK signalling pathway and can be used for research into multiple sclerosis.
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
C0114-12-ML750 100 µL
CALNA3, NT (Calmodulin-dependent Calcineurin A Subunit gamma Isoform, Serine/Threonine-protein Phosphatase 2B Catalytic Subunit gamma Isoform, CAM-PRP Catalytic Subunit, Calcineurin, Testis-specific Catalytic Subunit, PPP3CC, CNA3) (MaxLight 750) discontinued
Ask
View Details 